24.08.2013 Views

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Clinical genetics<br />

P01.210<br />

the high frequency <strong>of</strong> new mutations in dystrophin gene in<br />

the group <strong>of</strong> Polish patients affected with Duchenne?Becker<br />

muscular dystrophy<br />

J. G. Zimowski, M. Holding, W. Szirkowiec, E. Fidzianska, J. Kubalska, E.<br />

Zdzienicka, J. Zaremba;<br />

Institute <strong>of</strong> Psychiatry and Neurology, Warsaw, Poland.<br />

The frequency <strong>of</strong> Duchenne/Becker muscular dystrophy (DMD/BMD)<br />

among the newborn males is 1: 3500 . The constant <strong>of</strong> DMD/BMD incidence<br />

in male population is the evidence <strong>of</strong> the stable frequency<br />

<strong>of</strong> new mutations . Although men affected with DMD/BMD usually are<br />

not abble to reproduce incidence <strong>of</strong> the disease remains the same . It<br />

is assumed that 1/3 <strong>of</strong> single DMD/BMD male are the cases <strong>of</strong> new<br />

mutations .<br />

The study <strong>of</strong> carriership was carried out in a group <strong>of</strong> 249 mothers with<br />

one son affected with DMD/BMD in whom deletions in dystrophin gene<br />

were found . The studies <strong>of</strong> microsatellite sequences in the mothers<br />

revealed the presence <strong>of</strong> two different alleles in 138 females, therefore<br />

their carriership could be excluded . In 38 cases, in which mothers or<br />

daughters (sisters <strong>of</strong> affected males) were tested, the presence <strong>of</strong> the<br />

deletion was observed . The homozygozity was detected among 73 females<br />

. Some <strong>of</strong> them may be instances <strong>of</strong> hemizygozity . The exclusion<br />

<strong>of</strong> carriership in 55% <strong>of</strong> tested females is statistically different from the<br />

expected incidence <strong>of</strong> 33% .<br />

Support from State Committee Scientific Research (PBZ-KBN-122/<br />

P05/2004)<br />

P01.211<br />

two novel mutations in a Russian family with X-linked Emery-<br />

Dreifuss muscular dystrophy<br />

A. L. Chuhrova, T. B. Tiburkova, O. A. Schagina, E. L. Dadaly, A. V. Polyakov;<br />

Research centre for medical genetics, Moscow, Russian Federation.<br />

Emery-Dreifuss muscular dystrophy (EDMD) is a neuromuscular<br />

disease characterised by early contractures <strong>of</strong> Achilles-heel, elbows<br />

and spine, slow progression and symmetric weakness prominent in<br />

humero-peroneal muscle, cardiac conduction abnormality and/or cardiomyopathy<br />

and myopathic features . Two main modes <strong>of</strong> inheritance<br />

exist: X-linked and autosomal dominant . The frequency <strong>of</strong> the X-linked<br />

form is at 1:100 000 . EMD gene mutations, which encodes a nuclear<br />

membrane protein named emerin, are causes <strong>of</strong> the X-linked form <strong>of</strong><br />

EDMD . EMD gene has been mapped to the region Xq28 . Mutation<br />

analysis in EMD gene was performed by direct automatic sequence<br />

on Genetic Analyzer 3130 <strong>of</strong> all exons and exon-intron splices . We<br />

describe two novel mutations in the EMD gene in two Russian families<br />

. Mutations change nucleotide sequence <strong>of</strong> the sixth exon in the<br />

EMD gene . Family 1 had a c .664C>T (p .Gln222Stop) which causes a<br />

premature stop-codon at position 222 . In second family we found the<br />

mutation c .449+1delG which causes a disappearance donor spicingsite<br />

and subsequent - a premature stop-codone at position 221 .<br />

P01.212<br />

Genotype-phenotype correlates in autosomal recessive<br />

myotonia congenita<br />

I. Torrente 1 , A. Modoni 2 , E. Pisaneschi 1 , A. D’Amico 2 , L. Merlini 3 , G. Silvestri 2 ,<br />

E. M. Valente 1,4 , B. Dallapiccola 1,5 , M. Lo Monaco 2 ;<br />

1 CSS-Mendel Institute, Rome, Italy, 2 Department <strong>of</strong> Neuroscience, Catholic<br />

University <strong>of</strong> Rome, Rome, Italy, 3 Department <strong>of</strong> Experimental and Diagnostic<br />

Medicine, Division <strong>of</strong> Medical <strong>Genetics</strong>, University <strong>of</strong> Ferrara, Ferrara, Italy,<br />

4 Dpt <strong>of</strong> Medical and Surgical Pediatric Science, University <strong>of</strong> Messina, Messina,<br />

Italy, 5 Department <strong>of</strong> Experimental Medicine and Pathology, “La Sapienza”<br />

University <strong>of</strong> Rome, Rome, Italy.<br />

Myotonia Congenita (MC) is a chloride channel disorder due to mutations<br />

in the CLCN1 gene, inherited in autosomal dominant or recessive<br />

fashion . Beside myotonia <strong>of</strong> variable severity, transitory weakness<br />

(TW) can be detected, especially in recessive cases . Neurophysiologically,<br />

TW corresponds to a transitory depression (TD) <strong>of</strong> the compound<br />

muscle action potential during repetitive nerve stimulation (RNS) . We<br />

sought to correlate specific CLCN1 mutations with both TW and RNSinduced<br />

TD in 28 patients with recessive MC, by adopting a low frequency<br />

RNS protocol (3Hz for 500 stimuli) . The 3Hz RNS induced a<br />

significant TD in 19 patients, all <strong>of</strong> whom experienced variable episodes<br />

<strong>of</strong> TW. Several mutations appeared to correlate with specific<br />

TD patterns . In particular, the homozygous exon 9 deletion, C481X<br />

and IVS1+3A>T mutations (5 cases), as well as the compound heterozygous<br />

mutations G482R and T550R (1 case), always resulted in<br />

marked TD . Conversely, F167L seems to associate with mild or no TD,<br />

since 8 <strong>of</strong> 10 patients carrying this mutation (in compound heterozygosity<br />

with other mutations) had clinical absence <strong>of</strong> TW and a negative<br />

RNS test . Finally, the 3 patients heterozygous for the A531V change<br />

(compound with either R377X or R894X) presented a peculiar pattern<br />

<strong>of</strong> fluctuating TD. This study shows that the 3Hz RNS protocol, well<br />

tolerated by patients, is able to identify distinct neurophysiological TD<br />

patterns correlating with specific CLCN1 mutations. In turn, this may<br />

help understand the molecular basis underlying the phenotypic variability<br />

<strong>of</strong> MC, and may represent a step towards rational therapeutic<br />

strategies .<br />

P01.213<br />

DNA-diagnostics <strong>of</strong> myotonic dystrophy type 1 in Belarus<br />

T. Asadchuk, K. Mosse, N. Rumyantseva;<br />

Scientific-Practical Center “Mother and Child”, Minsk, Belarus.<br />

Myotonic dystrophy type 1 (DM1) is an autosomal dominant, multisystemic<br />

disease, with an estimated incidence <strong>of</strong> 1 in 8000 . DM is caused<br />

by expansion <strong>of</strong> CTG trinucleotide repeats located in the 3´ untranslated<br />

region <strong>of</strong> the myotonin protein kinase (DMPK) gene . The range <strong>of</strong><br />

expansion varies widely from 50 to several thousand repeats . First, we<br />

analysed the distribution <strong>of</strong> CTG-repeats in a cohort <strong>of</strong> normal individuals<br />

from the Belarusian population, and assessed the heterozygosity<br />

and number <strong>of</strong> alleles . PCR-products were analysed by the automated<br />

capillary electrophoresis on the ABI Prism 310 . We found 15 different<br />

allelic variants from 5 up to 28 CTG-repeats . The most common alleles<br />

had 5 repeats (38%) . The heterozygosity <strong>of</strong> the CTG polymorphism <strong>of</strong><br />

the Belarusian population was established as 78% . DNA-diagnostics<br />

<strong>of</strong> DM1 was done in 75 patients from 32 families showing different<br />

symptoms related to the disease . We found small expansions with 70<br />

and 86 CTG repeats in two affected men from two different families .<br />

PCR analysis also shows the high risk <strong>of</strong> mutation <strong>of</strong> the DMPK gene<br />

in 10 patients from 3 families, further confirmed by the Southern blot.<br />

So our PCR-based protocol allows amplification <strong>of</strong> normal-sized alleles<br />

and small expansions . For the large expansion Southern blot<br />

analysis is still the method <strong>of</strong> choice .<br />

P01.214<br />

molecular studies on two myotonic dystrophies (Dm1 and Dm2)<br />

in Polish patients group<br />

W. Krysa1 , A. Sulek-Piatkowska1 , M. Rajkiewicz1 , E. Szmidt-Salkowska2 , A.<br />

Kamińska2 , J. Zaremba1 ;<br />

1 2 Institute <strong>of</strong> Psychiatry and Neurology, Warsaw, Poland, Medical University,<br />

Warsaw, Poland.<br />

Myotonic dystrophies type 1 and type 2 (DM1 and DM2) are autosomal<br />

dominant disorders and share similar symptoms comprising myotonia,<br />

muscular dystrophy, and multisystem involvement (cataracts, diabetes<br />

and hypogonadism), but overall clinical picture <strong>of</strong> these two conditions<br />

is not identical .<br />

Molecular defect causing DM1 and DM2 is known as dynamic mutation<br />

in DMPK and ZNF7 genes respectively . Expansions up to 4000<br />

CTG repeats result in DM1 whereas a CCTG tetramers up to 11000 in<br />

patients with DM2 are observed .<br />

Molecular testing is the only reliable diagnostic definition in DM1 and<br />

DM2 . Prior to its introduction we have performed the analysis <strong>of</strong> normal<br />

alleles distribution in Polish control group . For DM1 locus the range is<br />

5-31 repeats and for DM2 the range <strong>of</strong> repeat motif varied from 123<br />

to 159 bp .<br />

For 5 years 372 individuals were tested for DM1 and/or DM2 by routine<br />

PCR, then all homozygous cases were analyzed by TP-PCR . Among<br />

them we have identified 76 pedigrees with 144 DM1 and 34 pedigrees<br />

with 35 DM2 mutation carriers . Within the group <strong>of</strong> DM1 patients we<br />

identified one family with a case <strong>of</strong> premutation which resulted in full<br />

mutation in the following generation. Moreover, we identified a patient<br />

with a coexistence <strong>of</strong> full mutation and premutation in DMPK gene .<br />

Among DM2 group we came across a family with two patients having<br />

extended alleles - 189 bp and 197 bp i .e . clearly above the normal<br />

range but below the considered as pathogenic range in DM2 (normal<br />

range 104-176 bp) .

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!